Merck Foundation marks “World Hypertension Day 2019” by their continuous programs of advancing hypertension and diabetes care in African and Asian countries

image

Click here for French version


Dr. Rasha Kelej, CEO of Merck Foundation with Merck Hypertension Awards Winners

  • Merck Foundation has been providing One Year  Diploma in Preventive Cardiovascular Medicine and Diabetes to young doctors from more than 40 African  and Asian countries

Merck Foundation, the philanthropic arm of Merck KGaA Germany marked ‘World Hypertension Day 2019’ by building hypertension care capacity in Africa and Asia through their nationwide programs.
 
Dr. Rasha Kelej, CEO of Merck Foundation “Merck Foundation launched ‘Merck Hypertension Award’ in 2016 in more than 40 African and Asian universities in partnership with health ministries, First Ladies and Academia. The winners are enrolled for One Year Post Graduate Diploma in Preventive Cardiovascular Medicine with University of South Wales, UK. The aim is to build a platform of hypertension experts in underserved communities”.

Winners of the Merck Hypertension Award 2017 were announced last year. The award attracted over 500 concept submission applications from universities in Africa and Asia. The winners from each university have been provided with an opportunity to study for a one-year online Post Graduate Diploma.


Dr. Joel Allotey from Ghana, Merck Hypertension Award Winner sharing his thoughts

“At Merck Foundation, we mark the “World Hypertension Day” every day through providing doctors with one year diploma to be diabetes and hypertension experts in more than 40 African and Asian countries. We strongly believe this is a critical strategy to achieve better hypertension and diabetes prevention and management in underserved communities” added Dr. Rasha Kelej. 


Message from Dr. Rasha Kelej, CEO of Merck Foundation

Dr. Joel Allotey from Ghana, an award winner from Merck Hypertension Award says, “I am very delighted to be given the opportunity receive Postgraduate Diploma in Preventative Cardiovascular Medicine at the University of South Wales, under the sponsorship of Merck Foundation. The course has exposed me to new scientific developments in interventions for the prevention of cardiovascular disease among individual patients as well as to larger at-risk population groups. I have gained expertise in current trends with regards to prevention of cardiovascular conditions, as well as identify research opportunities in cardiovascular medicine, peculiar to my local healthcare setting.”

One Click on icon below to
Download Merck Foundation App


Join the conversation on our social media platforms below and let your voice be heard

 Merck Foundation

 Merck Foundation

 Merck Foundation

 @MerckFoundation

 Merck Foundation

About Merck Foundation

The Merck Foundation, established in 2017, is the philanthropic arm of Merck KGaA Germany, aims to improve the health and wellbeing of people and advance their lives through science and technology. Our efforts are primarily focused on improving access to quality & equitable healthcare solutions in underserved communities, building healthcare and scientific research capacity and empowering people in STEM (Science, Technology, Engineering, and Mathematics) with a special focus on women and youth. All Merck Foundation press releases are distributed by e-mail at the same time they become available on the Merck Foundation Website.  Please visit www.merck-foundation.com to read more. To know more, reach out to our social media: Merck Foundation; Facebook, Twitter, Instagram, YouTube and Flicker.

About Merck

Merck is a leading science and technology company in healthcare, life science and performance materials. Almost 52,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions.

Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma.